New aspects of nanopharmaceutical delivery systems
- PMID: 18572633
- DOI: 10.1166/jnn.2008.274
New aspects of nanopharmaceutical delivery systems
Abstract
Nanobiotechnology, involving biological systems manufactured at the molecular level, is a multidisciplinary field that has fostered the development of nanoscaled pharmaceutical delivery devices. Micelles, liposomes, solid lipid nanoparticles, polymeric nanoparticles, functionalized nanoparticles, nanocrystals, cyclodextrins, dendrimers, nanotubes and metallic nanoparticles have been used as strategies to deliver conventional pharmaceuticals or substances such as peptides, recombinant proteins, vaccines and nucleotides. Nanoparticles and other colloidal pharmaceutical delivery systems modify many physicochemical properties, thus resulting in changes in the body distribution and other pharmacological processes. These changes can lead to pharmaceutical delivery at specific sites and reduce side effects. Therefore, nanoparticles can improve the therapeutic efficiency, being excellent carriers for biological molecules, including enzymes, recombinant proteins and nucleic acid. This review discusses different pharmaceutical carrier systems, and their potential and limitations in the field of pharmaceutical technology. Products with these technologies which have been approved by the FDA in different clinical phases and which are on the market will be also discussed.
Similar articles
-
The impact of nanobiotechnology on the development of new drug delivery systems.Curr Pharm Biotechnol. 2005 Feb;6(1):3-5. doi: 10.2174/1389201053167158. Curr Pharm Biotechnol. 2005. PMID: 15727551 Review.
-
Nanobiotechnology-based drug delivery in brain targeting.Curr Pharm Biotechnol. 2013;14(15):1264-74. doi: 10.2174/1389201015666140608143719. Curr Pharm Biotechnol. 2013. PMID: 24910011 Review.
-
Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging.Nanomedicine. 2012 Feb;8(2):147-66. doi: 10.1016/j.nano.2011.05.016. Epub 2011 Jun 7. Nanomedicine. 2012. PMID: 21703993 Review.
-
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23. Eur J Pharm Biopharm. 2015. PMID: 25813885 Review.
-
Nanosize drug delivery system.Curr Pharm Biotechnol. 2013;14(15):1221. doi: 10.2174/138920101415140804121008. Curr Pharm Biotechnol. 2013. PMID: 25106648
Cited by
-
Development and validation of an RP-HPLC method for CB13 evaluation in several PLGA nanoparticle systems.ScientificWorldJournal. 2012;2012:737526. doi: 10.1100/2012/737526. Epub 2012 Jun 18. ScientificWorldJournal. 2012. PMID: 22792051 Free PMC article.
-
Camptothecin-Loaded Liposomes with α-Melanocyte-Stimulating Hormone Enhance Cytotoxicity Toward and Cellular Uptake by Melanomas: An Application of Nanomedicine on Natural Product.J Tradit Complement Med. 2013 Apr;3(2):102-9. doi: 10.4103/2225-4110.110423. J Tradit Complement Med. 2013. PMID: 24716164 Free PMC article.
-
Analyzing collaboration networks and developmental patterns of nano-enabled drug delivery (NEDD) for brain cancer.Beilstein J Nanotechnol. 2015 Jul 31;6:1666-76. doi: 10.3762/bjnano.6.169. eCollection 2015. Beilstein J Nanotechnol. 2015. PMID: 26425417 Free PMC article.
-
Effects of silica nanoparticle supported ionic liquid as additive on thermal reversibility of human carbonic anhydrase II.Int J Biol Macromol. 2012 Dec;51(5):933-8. doi: 10.1016/j.ijbiomac.2012.07.023. Epub 2012 Jul 22. Int J Biol Macromol. 2012. PMID: 22829053 Free PMC article.
-
Nanosuspended branched chain amino acids: the influence of stabilizers on their solubility and colloidal stability.Food Sci Biotechnol. 2017 May 29;26(3):573-579. doi: 10.1007/s10068-017-0100-8. eCollection 2017. Food Sci Biotechnol. 2017. PMID: 30263581 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources